Holen Sie sich die Stockscreener-App
2.415
3.04%
-0.055
Finanzdaten der Allogene Therapeutics Inc-Aktie (ALLO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
44.90
|
- | 65.19 | 60.49 | 71.77 |
| Operating Income/Loss |
-44.90
|
- | -65.19 | -60.49 | -71.77 |
| Nonoperating Income/Loss |
3.501
|
- | 5.458 | 0.994 | 5.481 |
| Income/Loss From Continuing Operations Before Tax |
18.73%
-41.40
|
-50.94 | -59.73 | -59.50 | -66.29 |
| Income/Loss From Continuing Operations After Tax |
18.73%
-41.40
|
-50.94 | -59.73 | -59.94 | -66.29 |
|
Net Income/Loss
|
18.73%
-41.40
|
-50.94 | -59.73 | -59.94 | -66.29 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
222.04
|
- | 215.36 | 5.2919 | 209.19 |
| Diluted Average Shares |
222.04
|
- | 215.36 | 5.2919 | 209.19 |
| Basic Earnings Per Share |
-0.19
|
- | -0.28 | -0.28 | -0.32 |
| Diluted Earnings Per Share |
-0.19
|
- | -0.28 | -0.28 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.18%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):